In the original article, there were mistakes in Table 6, Table 7, Table 9 as published. The numbers of patients in [Table 6](#T6){ref-type="table"} and **Table 9** were incorrect. The contents in [Table 7](#T7){ref-type="table"} and [Table 9](#T9){ref-type="table"} were repetitive to some degree in that we had shown the association between adiponectin with metabolic syndrome and HW phenotype. Therefore, for this Correction, we analyzed the association between adiponectin and metabolic syndrome, and the association in pre- and postmenopausal subgroups in [Table 7](#T7){ref-type="table"}. In [Table 9](#T9){ref-type="table"}, we converted the numerical variable into categorical variable, which should provide better guide for clinical practice. In our view, this avoids the repetition. These new tables appear below as Tables 6, 7, 9. The authors apologize for these errors and any confusion that may have arisen due to them and hopes these additional tables sufficiently addresses them.

###### 

Association between HW phenotype and breast cancer by logistic regression.

                                                           **All subjects(*****n*** **=** **595)**   **Premenopausal(*****n*** **=** **383)**   **Postmenopausal(*****n*** **=** **209)**   **ER+/PR+(*****n*** **=** **293)**   **ER+/PR--(*****n*** **=** **59)**   **ER--/PR--(*****n*** **=** **148)**                                                                                                           
  -------------------------------------------------------- ----------------------------------------- ------------------------------------------ ------------------------------------------- ------------------------------------ ------------------------------------ -------------------------------------- ------ ------------ ------- ------ ------------ ------- ------ ------------ ------- ------ ------------ -------
  **Univariate model**                                                                                                                                                                                                                                                                                                                                                                                               
  WC+TG (normal = reference)                               1.66                                      1.10--2.50                                 0.016                                       1.63                                 0.95--2.82                           0.077                                  1.72   0.91--3.22   0.09    2.06   1.29--3.27   0.002   1.70   0.73--4.00   0.222   1.43   0.76--2.67   0.266
  **Multivariate model[^a^](#TN1){ref-type="table-fn"}**                                                                                                                                                                                                                                                                                                                                                             
  WC+TG (normal=reference)                                 1.56                                      1.02--2.39                                 0.039                                       1.49                                 0.85--2.63                           0.167                                  1.60   0.82--3.12   0.170   1.95   1.21--3.13   0.006   1.71   0.72--4.08   0.225   1.21   0.63--2.33   0.571

*WC, waist circumference; TG, triglycerides; ER, estrogen receptor; PR, progesterone receptor*.

*Adjusted for age, number of childbirths, age at menarche, breastfeeding, smoking, alcohol use, family history of breast cancer, and contraceptive drug use*.

###### 

Association between total adiponectin, HMW adiponectin, HMW/total ratio, and metabolic syndrome.

                      **All subjects**   **Premenopausal**   **Postmenopausal**                                                                           
  ------------------- ------------------ ------------------- -------------------- --------------- --------------- ------- --------------- --------------- -------
  Total adiponectin   5.970 ± 3.789      2.807 ± 2.007       0.004                5.960 ± 3.830   6.637 ± 3.558   0.054   5.979 ± 3.762   6.909 ± 3.875   0.022
  HMW adiponectin     2.408 ± 1.870      2.807 ± 2.007       0.004                2.371 ± 1.830   2.757 ± 1.958   0.037   2.445 ± 1.915   2.935 ± 2.116   0.024
  HMW/total ratio     0.39 ± 0.14        0.41 ± 0.16         0.101                0.39 ± 0.14     0.40 ± 0.17     0.233   0.39 ± 0.15     0.42 ± 0.15     0.150

*MetS, metabolic syndrome; HMW, high molecular weight*.

###### 

The association among metabolic syndrome, breast cancer, and adiponectin.

                                               **Controls**   **All cases**           **ER+/PR+**           **ER+/PR--**           **ER--/PR--**   
  ------------------------ ------------------- -------------- --------------- ------- ------------- ------- -------------- ------- --------------- -------
  **METABOLIC SYNDROME**                                                                                                                           
  YES                                                                                                                                              
                           Total adiponectin                                  0.362                 0.944                  0.764                   0.203
                           High                26 (22.2%)     27 (17.8%)              17 (21.8%)            3 (15.8%)              5 (12.8%)       
                           Low                 91 (77.8%)     125 (82.2%)             61 (78.2%)            16 (84.2%)             34 (87.2%)      
                           HMW adiponectin                                    0.296                 0.597                  0.113                   0.403
                           High                66 (56.4%)     76 (50.0%)              41 (52.6%)            7 (36.8%)              19 (48.7%)      
                           Low                 51 (43.6%)     76 (50.0%)              37 (47.4%)            12 (63.2%)             20 (51.3%)      
                           HMW/total ratio                                    0.354                 0.069                  0.805                   0.711
                           High                59 (50.4%)     68 (44.7%)              29 (37.2%)            9 (47.4%)              21 (53.8%)      
                           Low                 58 (49.6%)     84 (55.3%)              49 (62.8%)            10 (52.6%)             18 (46.2%)      
  No                                                                                                                                               
                           Total adiponectin                                  0.097                 0.121                  0.339                   0.118
                           High                106 (25.5%)    92 (20.8%)              43 (20.0%)            13 (32.5%)             20 (18.3%)      
                           Low                 309 (74.5%)    351 (79.2%)             172 (80.0%)           27 (67.5%)             89 (81.7%)      
                           HMW adiponectin                                    0.507                 0.970                  0.588                   0.244
                           High                287 (69.2%)    297 (67.0%)             149 (69.3%)           26 (65.0%)             69 (63.3%)      
                           Low                 128 (30.8%)    146 (33.0%)             66 (30.7%)            14 (35.0%)             40 (36.7%)      
                           HMW/total ratio                                    0.359                 0.229                  0.873                   0.062
                           High                213 (51.3%)    213 (48.2%)             99 (46.3%)            20 (50.0%)             45 (41.3%)      
                           Low                 202 (48.7%)    229 (51.8%)             115 (53.7%)           20 (50.0%)             64 (58.7%)      
  **HW PHENOTYPE**                                                                                                                                 
  YES                                                                                                                                              
                           Total adiponectin                                  0.005                 0.028                  1.000                   0.043
                           High                14 (35.9%)     9 (13.0%)               6 (14.6%)             2 (28.6%)              1 (6.7%)        
                           Low                 25 (64.1%)     60 (87.0%)              35 (85.4%)            5 (71.4%)              14 (93.3%)      
                           HMW adiponectin                                    0.717                 0.527                  0.424                   0.583
                           High                24 (61.5%)     40 (58.0%)              28 (68.3%)            3 (42.9%)              8 (53.3%)       
                           Low                 15 (38.5%)     29 (42.0%)              13 (31.7%)            4 (57.1%)              7 (46.7%)       
                           HMW/total ratio                                    0.570                 0.263                  1.000                   0.839
                           High                17 (43.6%)     34 (49.3%)              23 (56.1%)            3 (42.9%)              7 (46.7%)       
                           Low                 22 (56.4%)     35 (50.7%)              18 (43.9%)            4 (57.1%)              8 (53.3%)       
  NO                                                                                                                                               
                           Total adiponectin                                  0.247                 0.442                  0.632                   0.150
                           High                118 (23.9%)    110 (20.9%)             54 (21.4%)            14 (26.9%)             24 (18.0%)      
                           Low                 375 (76.1%)    416 (79.1%)             198 (78.6%)           38 (73.1%)             109 (82.0%)     
                           HMW adiponectin                                    0.252                 0.505                  0.191                   0.157
                           High                329 (66.7%)    333 (63.3%)             162 (64.3%)           30 (57.7%)             80 (60.2%)      
                           Low                 164 (33.3%)    193 (36.7%)             90 (35.7%)            22 (42.3%)             53 (39.8%)      
                           HMW/total ratio                                    0.136                 0.011                  0.813                   0.132
                           High                255 (51.7%)    247 (47.0%)             105 (41.8%)           26 (50.0%)             59 (44.4%)      
                           Low                 238 (48.3%)    278 (53.0%)             146 (58.2%)           26 (50.0%)             74 (55.6%)      

*ER, estrogen receptor; PR, progesterone receptor*.

*Cut-off value of high and low level for total adiponectin, HMW adiponectin, and HMW/total ratio is 8.768, 1.635, and 0.399, respectively*.

In the original article, corresponding text of Table 6, Table 7, and Table 9 was corrected.

A correction has been made to Abstract, Results, Paragraph number 1:

In addition, total adiponectin levels among breast cancer patients were much lower than among controls (*p* = 0.005) only in the HW phenotype subgroup. Furthermore, the HW phenotype was associated with increased risk of estrogen receptor/progesterone receptor-positive (ER+/PR+) breast cancer, with a 95% (OR = 1.95, 95% CI:1.21--3.13) increase. However, there was no significant association between the HW phenotype and both ER+/PR-- and ER--/PR-- subtypes.

A correction has been made to Results, Cluster Mode of HW Phenotype Significantly Increases Breast Cancer Risk, Paragraph number 3:

HW phenotype was associated with ER+/PR+ breast cancer, with a 95% (OR = 1.95, 95% CI:1.21--3.13) increase in risk for women with a positive HW phenotype. However, there was no significant association between HW phenotype and both ER+/PR-- and ER--/PR-- subtypes.

A correction has been made to Results, Adiponectin Might Be the Mechanism Linking Metabolic Syndrome to Breast Cancer, Paragraph number 2:

total adiponectin levels among breast cancer patients were much lower than among the controls(*p* = 0.005) in the HW phenotype subgroup.

A correction has been made to Results, Adiponectin Might Be the Mechanism Linking Metabolic Syndrome to Breast Cancer, Paragraph number 3:

there was a significant difference of total adiponectin in ER+/PR+ (*p* = 0.028) and ER--/PR-- (*p* = 0.043) breast cancer compared to the controls, who were much lower in the HW phenotype subgroup.

A correction has been made to Discussion, Paragraph number 6:

We revealed that HW phenotype was an independent risk factor for the ER+/PR+ subtype.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
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